Less than a month after that Super Bowl ad aired, the FDA began announcing new policies that require compounding pharmacies to stop making compounded semaglutide and tirzepatide (the active ingredients in Ozempic and Mounjaro, respectively), which also meansin theorythat telemedicine companies need to stop selling these drugs
Despite the rejection, CMS has indicated that it might cover obesity medication in future rulemaking
The vast majority of personal injury cases, including those within an MDL, resolve through settlements before reaching a courtroom
Lemonaid does not offer behavior coaching, nutrition support, fitness support, or a patient community
Glucagon-like Peptide-1 and its Class B G protein-coupled receptors: a long march to therapeutic successes